Rituximab Reduces Kidney Inflammation In Patients With Lupus
Treatment with the targeted drug rituximab can significantly benefit some patients with severe lupus nephritis who do not respond to conventional therapy, according to a new study. The findings indicate that this immunosuppressive agent could improve the health of patients who have few other treatment options and who might otherwise develop end-stage renal disease.
Related Posts
Tags: inflammation, kidney, lupus, patients, reduces, rituximab
This entry was posted on Friday, March 6th, 2009 at 11:03 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
